CompletedPhase 3NCT00412360
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
Studying Chronic myeloid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical College of Wisconsin
- Principal Investigator
- Mary Horowitz, MD, MS, LCSWCenter for International Blood and Marrow Transplant Research
- Intervention
- Single Umbilical Cord Blood Unit Transplant(biological)
- Enrollment
- 224 enrolled
- Eligibility
- 1-21 years · All sexes
- Timeline
- 2006 – 2014
Study locations (30)
- University of Alabama, Birmingham, Alabama, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- City of Hope National Medical Center, Duarte, California, United States
- Childrens Hospital at Oakland, Oakland, California, United States
- UCSD/Rady Childrens Hospital, San Diego, California, United States
- University of California, San Francisco (Peds), San Francisco, California, United States
- The Children's Hospital of Denver, Denver, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Florida College of Medicine (Shands), Gainesville, Florida, United States
- Nemours Childrens Clinic, Jacksonville, Florida, United States
- University of Miami, Miami, Florida, United States
- All Children's Hospital, St. Petersburg, Florida, United States
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Indiana University Medical Center, Indianapolis, Indiana, United States
- University of Louisville/Kosiar Children's Hospital, Louisville, Kentucky, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · Blood and Marrow Transplant Clinical Trials Network · National Cancer Institute (NCI) · National Marrow Donor Program
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00412360 on ClinicalTrials.govOther trials for Chronic myeloid leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07354074Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPNovartis Pharmaceuticals
- RECRUITINGNCT07375355Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in ChinaNovartis Pharmaceuticals
- ENROLLING BY INVITATIONNCT07383298Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated PhaseQian Jiang
- RECRUITINGPHASE2NCT06817720Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic PhaseM.D. Anderson Cancer Center
- RECRUITINGNCT07061145A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid LeukemiaAzienda USL Reggio Emilia - IRCCS
- RECRUITINGPHASE2NCT06409936PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CMLGruppo Italiano Malattie EMatologiche dell'Adulto
- RECRUITINGPHASE2NCT06514534Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.Novartis Pharmaceuticals
- RECRUITINGPHASE1NCT06787144ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese ParticipantsEnliven Therapeutics